Publicaciones en las que colabora con Ángel Concha López (63)

2021

  1. CRC: A Darwinian model of cellular immunoselection

    Foundations of Colorectal Cancer (Elsevier), pp. 529-541

  2. Tumor escape phenotype in bladder cancer is associated with loss of HLA class I expression, T-cell exclusion and stromal changes

    International Journal of Molecular Sciences, Vol. 22, Núm. 14

2018

  1. HLA class I alterations in breast carcinoma are associated with a high frequency of the loss of heterozygosity at chromosomes 6 and 15

    Immunogenetics, Vol. 70, Núm. 10, pp. 647-659

  2. HLA class I loss and PD-L1 expression in lung cancer: Impact on T-cell infiltration and immune escape

    Oncotarget, Vol. 9, Núm. 3, pp. 4120-4133

2015

  1. Cáncer colorrectal: un modelo darwiniano de inmuno-selección celular

    Abordaje multidisciplinar de cáncer colorrectal (Andavira), pp. 453-470

2014

  1. ESR1 gene promoter region methylation in free circulating DNA and its correlation with estrogen receptor protein expression in tumor tissue in breast cancer patients

    BMC Cancer, Vol. 14, Núm. 1

2013

  1. Expression profiling of breast tumors based on human epidermal growth factor receptor 2 status defines migration-related genes

    Pathobiology, Vol. 80, Núm. 1, pp. 32-40

  2. Linfocitos CD4 como factor protector frente a la infección por genotipos oncogénicos del virus del papiloma humano en la mucosa del canal anal de varones que tienen sexo con varones infectados por el virus de la inmunodeficiencia humana

    Medicina Clinica, Vol. 140, Núm. 5, pp. 193-199

2012

  1. Biomedical application of fuzzy association rules for identifying breast cancer biomarkers

    Medical and Biological Engineering and Computing, Vol. 50, Núm. 9, pp. 981-990

  2. Genome-wide differential genetic profiling characterizes colorectal cancers with genetic instability and specific routes to HLA class I loss and immune escape

    Cancer Immunology, Immunotherapy, Vol. 61, Núm. 6, pp. 803-816

  3. Implication of the β2-microglobulin gene in the generation of tumor escape phenotypes

    Cancer Immunology, Immunotherapy, Vol. 61, Núm. 9, pp. 1359-1371

  4. MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy

    Journal of Translational Medicine, Vol. 10, Núm. 1

2011

  1. Giant proliferating trichilemmal malignant tumor

    Indian Journal of Dermatology, Venereology and Leprology

  2. HER2 status in breast cancer: Experience of a Spanish National Reference Centre

    Clinical and Translational Oncology, Vol. 13, Núm. 5, pp. 335-340

  3. Leukocyte infiltrate in gastrointestinal adenocarcinomas is strongly associated with tumor microsatellite instability but not with tumor immunogenicity

    Cancer Immunology, Immunotherapy, Vol. 60, Núm. 6, pp. 869-882

  4. Unknown: A woman with reddish nodule on the skin of the breast

    Dermatology Online Journal, Vol. 17, Núm. 2, pp. 11

2010

  1. Analysis of breast cancer genomic data by fuzzy association rule mining

    Database Technology For Life Sciences And Medicine (World Scientific Publishing Co.), pp. 241-278

  2. Higher HLA class i expression in renal cell carcinoma than in autologous normal tissue

    Tissue Antigens, Vol. 75, Núm. 2, pp. 110-118

  3. Real-time RT-PCR analysis for evaluating the Her2/neu status in breast cancer

    Pathobiology, Vol. 77, Núm. 1, pp. 38-45

2009

  1. A polymorphism in the interleukin-10 promoter affects the course of disease in patients with clear-cell renal carcinoma

    Human Immunology, Vol. 70, Núm. 1, pp. 60-64